(Total Views: 118)
Posted On: 11/20/2020 10:50:48 AM
Post# of 27336

$MTNB News Article - Matinas BioPharma Awarded up to $3.75 Million from the Cystic Fibrosis Foundation to Support Development of Oral Amikacin (MAT2501) for the Treatment of NTM Infections in Cystic Fibrosis Patients https://marketwirenews.com/news-releases/mati...38335.html


My Twitter: WhyteStocks